Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accumulated Expenses (2016 - 2026)

Biomerica's Accumulated Expenses history spans 16 years, with the latest figure at $608000.0 for Q1 2026.

  • On a quarterly basis, Accumulated Expenses fell 0.65% to $608000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $608000.0, a 0.65% decrease, with the full-year FY2025 number at $655000.0, up 13.32% from a year prior.
  • Accumulated Expenses hit $608000.0 in Q1 2026 for Biomerica, up from $545000.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for BMRA hit a ceiling of $702000.0 in Q1 2024 and a floor of $236000.0 in Q2 2022.
  • Historically, Accumulated Expenses has averaged $588286.4 across 5 years, with a median of $601000.0 in 2024.
  • Biggest five-year swings in Accumulated Expenses: soared 132.2% in 2023 and later decreased 12.82% in 2025.
  • Tracing BMRA's Accumulated Expenses over 5 years: stood at $697179.0 in 2022, then decreased by 4.19% to $668000.0 in 2023, then fell by 10.03% to $601000.0 in 2024, then fell by 9.32% to $545000.0 in 2025, then rose by 11.56% to $608000.0 in 2026.
  • Business Quant data shows Accumulated Expenses for BMRA at $608000.0 in Q1 2026, $545000.0 in Q4 2025, and $591000.0 in Q3 2025.